127 related articles for article (PubMed ID: 15998657)
41. Antioxidant supplementation may improve renal transplant function: a preliminary report.
Loong CC; Chang YH; Wu TH; King KL; Yang WC; Wu CW; Lui WY
Transplant Proc; 2004 Oct; 36(8):2438-9. PubMed ID: 15561272
[TBL] [Abstract][Full Text] [Related]
42. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
Uslu A; Töz H; Sen S; Alkan FT; Nart A; Aykas A; Doğan M; Postaci H; Sahin T; Simşek C
Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics and pharmacodynamics in renal transplant recipients under treatment with cyclosporine and Myfortic.
Brunet M; Crespo M; Millán O; Serón D; Torregrosa V; Jiménez O; Moreso F; Martorell J; Grinyo JM; Oppenheimer F
Transplant Proc; 2007 Sep; 39(7):2160-2. PubMed ID: 17889124
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and risk factors of renal dysfunction after liver transplant: a single-center experience.
Dehghani SM; Derakhshan A; Taghavi SA; Gholami S; Jalaeian H; Malek-Hosseini SA
Exp Clin Transplant; 2008 Mar; 6(1):25-9. PubMed ID: 18405241
[TBL] [Abstract][Full Text] [Related]
45. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation.
Bruno RS; Leonard SW; Atkinson J; Montine TJ; Ramakrishnan R; Bray TM; Traber MG
Free Radic Biol Med; 2006 Feb; 40(4):689-97. PubMed ID: 16458200
[TBL] [Abstract][Full Text] [Related]
46. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
Bakar F; Keven K; Dogru B; Aktan F; Erturk S; Tuzuner A; Erbay B; Nebioglu S
Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
[TBL] [Abstract][Full Text] [Related]
47. Folate supplementation fails to affect vascular function and carotid artery intima media thickness in cyclosporin A-treated renal transplant recipients.
Austen SK; Fassett RG; Geraghty DP; Coombes JS
Clin Nephrol; 2006 Nov; 66(5):373-9. PubMed ID: 17140167
[TBL] [Abstract][Full Text] [Related]
48. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
Chang HR; Lin CC; Lian JD
Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
[TBL] [Abstract][Full Text] [Related]
49. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
Joss N; Rodger RS; McMillan MA; Junor BJ
Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
[TBL] [Abstract][Full Text] [Related]
50. Inadequate dietary calcium and vitamin D intakes in renal-transplant recipients in Ireland.
Lynch IT; Eustace JA; Plant WD; Cashman KD; O'Keefe M; Lordan S; Moloney R
J Ren Nutr; 2007 Nov; 17(6):408-15. PubMed ID: 17971313
[TBL] [Abstract][Full Text] [Related]
51. Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen.
Lisik W; Schoenberg L; Lasky RE; Kahan BD
Transplant Proc; 2007 Dec; 39(10):3086-92. PubMed ID: 18089328
[TBL] [Abstract][Full Text] [Related]
52. Contrast enhanced sonography shows superior microvascular renal allograft perfusion in patients switched from cyclosporine A to everolimus.
Kihm LP; Hinkel UP; Michael K; Sommerer C; Seckinger J; Morath C; Zeier M; Schwenger V
Transplantation; 2009 Jul; 88(2):261-5. PubMed ID: 19623023
[TBL] [Abstract][Full Text] [Related]
53. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
Madsen JK; Sørensen SS; Hansen HE; Pedersen EB
Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
[TBL] [Abstract][Full Text] [Related]
54. Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients.
Mandla R; Midtvedt K; Line PD; Hartmann A; Bergan S
Transpl Int; 2006 Jan; 19(1):44-53. PubMed ID: 16359376
[TBL] [Abstract][Full Text] [Related]
55. MDR1 C3435T polymorphisms correlate with cyclosporine levels in de novo renal recipients.
Foote CJ; Greer W; Kiberd BA; Fraser A; Lawen J; Nashan B; Belitsky P
Transplant Proc; 2006 Nov; 38(9):2847-9. PubMed ID: 17112845
[TBL] [Abstract][Full Text] [Related]
56. Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus.
White M; Ross H; Haddad H; LeBlanc MH; Racine N; Pflugfelder P; Giannetti N; Davies R; Azevedo E; Isaac D; Burton J; Ferguson R; Genest J
Transplantation; 2006 Sep; 82(6):763-70. PubMed ID: 17006323
[TBL] [Abstract][Full Text] [Related]
57. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
[TBL] [Abstract][Full Text] [Related]
58. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
59. The beneficial effect of dietary antioxidant supplementation on platelet aggregation and cyclosporine treatment in heart transplant recipients.
de Lorgeril M; Boissonnat P; Salen P; Monjaud I; Monnez C; Guidollet J; Ferrera R; Dureau G; Ninet J; Renaud S
Transplantation; 1994 Jul; 58(2):193-5. PubMed ID: 8042237
[TBL] [Abstract][Full Text] [Related]
60. [Effect of antioxidant supplementation over oxidative stress and quality of life in cervical cancer].
Fuchs-Tarlovsky V; Bejarano-Rosales M; Gutiérrez-Salmeán G; Casillas MA; López-Alvarenga JC; Ceballos-Reyes GM
Nutr Hosp; 2011; 26(4):819-26. PubMed ID: 22470030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
